BrainsGate completes USD14m financing round led by BNP Joint Capital Fund and SPERO
BrainsGate, the developer of a novel proprietary treatment for Ischemic Stroke, has secured a USD14 million investment at a USD147 million pre-money valuation. The new financing is designed to fund the company through PMA approval and production readiness.